Slowly but surely: how to reduce hepatitis C prevalence
Modest increases in hepatitis C treatment rates amongst people who inject drugs will significantly reduce infection prevalence, resulting in benefits for both individuals and the public.
Download report
Professor Margaret Hellard AM
For almost two decades Margaret’s work has centred around infectious diseases, preventing their transmission and identifying the impact of these infections in vulnerable populations. A researcher and clinician, her principal research interests are in the epidemiology of blood-borne viruses (BBVs) HIV, hepatitis B and hepatitis C, sexually transmitted infections, and improving the management of individuals who already have the infection.
EMAIL